BioCorRx raises $200K from LGH via $220K note, warrant, and 24K inducement shares

On November 10, 2023, BioCorRx Inc., a Nevada corporation (the “Company”), entered into a securities purchase agreement (the “SPA”) with LGH Investments, LLC, a Wyoming limited liability company (the “LGH”), whereby LGH purchased from the Company, for a purchase price of $200,000 (the “Purchase Price”) (i) a promissory note of the Company in the original principal amount of $220,000.00 (the “Note”), (ii) a common stock purchase warrant for 200,000 shares (the “Warrant”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 24,000 restricted shares of Common Stock (the “Inducement Shares”, and collectively with the Note and Warrant, the “Securities”).